Genentech: Brian Yaspan Distinguished Scientist, Human Genetics

Por um escritor misterioso

Descrição

Breakthrough science. One moment, one day, one person at a time.
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Age-related Macular Degeneration patient deep phenotyping and
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Distinctive cross-ancestry genetic architecture for age-related
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Genentech: Our Scientists
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Distinctive cross-ancestry genetic architecture for age-related
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Genentech: Our Scientists
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Marion Jeanne - Principal Scientist - Genentech
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Age-related Macular Degeneration patient deep phenotyping and
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Genentech: Mary Keir Distinguished Scientist and Director, Human
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Genentech: Our Scientists
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Distinctive cross-ancestry genetic architecture for age-related
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Lineage Cell Therapeutics Inc (LCTX) Stock Message Board
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Age-related Macular Degeneration patient deep phenotyping and
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Distinctive cross-ancestry genetic architecture for age-related
Genentech: Brian Yaspan  Distinguished Scientist, Human Genetics
Frontiers Use of Mendelian Randomization for Identifying Risk
de por adulto (o preço varia de acordo com o tamanho do grupo)